Infiltrate – mowl,Infiltrate – mowl,ASH 2024: Subcutaneous Mosunetuzumab Leads to High Rates of Durable Responses, Low Rates of Cytokine Release Syndrome, and Non-Inferior Exposure Compared with Intravenous Administration in Patients with Relapsed/Refractory Follicular Lymphoma: Primary ,Bad Boy Maverick Kohler® Confidant 747cc 60,A patient‐friendly 16‐channel transmit/64‐channel receive coil array for combined head–neck MRI at 7 Tesla - May - 2022 - Magnetic Resonance in Medicine - Wiley Online Library